Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Alzheimer’s, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others), By Distribution Channel (Direct Sales v/s Indirect Sales), By Region & Competition, 2020-2030F

Market Overview

Global Oral Clinical Nutrition Market was valued at USD 15.89 billion in 2024 and is expected to reach USD 22.14 billion by 2030 with a CAGR of 5.68% during the forecast period. Global Oral Clinical Nutrition Market is poised to grow at an impressive rate during the forecast period on account of rising incidence of chronic diseases, and an increasing focus on patient-centric care. In addition, the growing prevalence of malnutrition and related conditions such as sarcopenia and cachexia are also fueling demand for the products.

Increasing demand for products that provide essential nutrients to patients who are unable to consume adequate amounts of food through normal means. This market encompasses a wide range of products, including supplements, enteral feeding formulas, and medical foods, all designed to provide patients with the nutrients they need to support their recovery and maintain their health.

Key Market Drivers

Increasing Geriatric Population and Associated Malnutrition Risks

One of the primary drivers for the global oral clinical nutrition market is the rising aging population, which is closely associated with higher risks of malnutrition and chronic illnesses. As people age, they often experience a natural decline in appetite, digestive efficiency, and overall nutritional intake. This can lead to malnutrition, weight loss, muscle wasting, and a compromised immune system. Oral clinical nutrition products play a crucial role in addressing these deficiencies by providing concentrated forms of essential nutrients, proteins, vitamins, and minerals in palatable and easily digestible forms.

Globally, the aging population is growing rapidly. According to WHO, by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of people aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Many governments are increasingly emphasizing senior healthcare services and home-based nutritional support programs. For example, several countries in Europe and Asia have implemented national nutrition guidelines and funded nutrition supplementation programs targeting older adults. These initiatives increase the visibility and accessibility of oral clinical nutrition products.

Furthermore, hospitals, nursing homes, and long-term care facilities are also prioritizing nutritional interventions, especially post-surgery or during recovery from illness, which boosts the demand. With the elderly population expected to continue expanding in the coming decades, the demand for oral clinical nutrition is expected to rise substantially as a preventive and therapeutic healthcare strategy.

Rising Prevalence of Chronic Diseases and Recovery Nutrition

Another significant factor propelling the market is the increasing prevalence of chronic conditions such as cancer, diabetes, gastrointestinal disorders, and renal diseases. Patients with these conditions often require enhanced nutritional support to manage symptoms, recover post-treatment, and maintain their overall health. Oral clinical nutrition serves as a key therapeutic adjunct in managing the nutritional status of patients undergoing chemotherapy, dialysis, or surgery. According to WHO, Noncommunicable diseases (NCDs) killed at least 43 million people in 2021, equivalent to 75% of non-pandemic-related deaths globally.

In 2021, 18 million people died from an NCD before age 70 years; 82% of these premature deaths occur in low- and middle-income countries. Of all NCD deaths, 73% are in low- and middle-income countries. Cardiovascular diseases account for most NCD deaths, or at least 19 million deaths in 2021, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million including kidney disease deaths caused by diabetes).

Healthcare providers are placing more emphasis on nutritional interventions as part of holistic treatment plans, especially as studies continue to show improved clinical outcomes when patients receive adequate nutrition. Malnutrition among hospitalized patients remains a global concern, often resulting in longer hospital stays and increased healthcare costs. Therefore, nutrition-focused care, particularly through oral clinical supplements, is becoming a cornerstone of clinical protocols in both inpatient and outpatient settings.

Government health systems are beginning to acknowledge the role of nutrition in chronic disease management and recovery. Policies supporting hospital nutrition programs, reimbursement for nutritional products, and integration of dietitians into clinical teams are boosting the growth of this market. As chronic diseases remain a global health burden, the demand for effective, easy-to-administer nutritional support continues to grow.

Download Free Sample Report

Key Market Challenges

High Cost and Limited Reimbursement in Developing Regions

One of the major challenges hindering the growth of the global oral clinical nutrition market is the relatively high cost of specialized nutritional products, especially in low- and middle-income countries. While these supplements are critical in preventing malnutrition and supporting recovery, their affordability remains a barrier for many patients, particularly in regions with underfunded healthcare systems.

In several countries, oral clinical nutrition products are not covered under national health insurance schemes or public reimbursement programs. This places the financial burden on patients and their families, often leading to suboptimal nutritional support. The lack of inclusion in essential medicine lists or government procurement plans further limits accessibility, especially in rural and underserved areas.

Additionally, the cost of manufacturing high-quality, disease-specific formulations contributes to higher retail prices. This creates a disparity between developed and developing markets, where adoption is significantly lower due to economic constraints. Although some NGOs and public health organizations have launched nutrition assistance programs, widespread access remains limited.

To overcome this challenge, collaboration between governments, manufacturers, and public health bodies is essential. Initiatives aimed at subsidizing costs, expanding reimbursement coverage, and promoting local production of cost-effective clinical nutrition products could improve accessibility and drive market growth in developing regions.

Regulatory and Labelling Complexities

Navigating the regulatory landscape for oral clinical nutrition products remains a substantial challenge for manufacturers. These products often fall in a gray area between dietary supplements and pharmaceutical interventions, leading to ambiguity in classification, safety standards, and labelling requirements. Regulatory frameworks vary significantly between countries and even within regions, complicating global product launches and distribution.

For example, in some countries, clinical nutrition products must undergo stringent approval processes like drug trials, including clinical efficacy data and safety assessments. In contrast, other markets classify them as food supplements, requiring only basic quality assurance. This lack of harmonization affects product timelines, costs, and the ability to market products effectively.

Labelling standards are further complicated matters. Guidelines for nutrient content claims, health claims, and usage instructions vary widely, requiring companies to create multiple product versions to comply with local regulations. Missteps in labelling can result in penalties, product recalls, or bans, impacting brand reputation.

Moreover, increasing scrutiny by regulatory bodies and rising consumer expectations around transparency and evidence-based claims are prompting stricter compliance requirements. As a result, companies must invest heavily in regulatory expertise and legal advisory services to ensure adherence, which may restrict the entry of small and medium players into the market.

Key Market Trends

Personalization in Clinical Nutrition Formulations

Personalization is emerging as a transformative trend in oral clinical nutrition, with manufacturers developing specialized products tailored to individual needs. This shift is driven by the recognition that nutritional requirements vary significantly across patient demographics, disease states, age groups, and genetic profiles. Personalized nutrition allows for more targeted treatment plans, improving patient adherence and outcomes.

Technological advances, particularly in nutrigenomics and digital health monitoring, are enabling healthcare providers to better assess patients’ metabolic profiles and nutritional deficiencies. These insights allow for customized formulations that address specific deficiencies or therapeutic goals, whether it’s boosting immunity, improving muscle mass, or aiding recovery from gastrointestinal issues.

Furthermore, there's a growing demand for disease-specific nutrition, such as products for oncology patients, diabetic individuals, and those with kidney or liver dysfunction. As consumers become more health-conscious and involved in their care, the market is witnessing a shift from generic products to those that promise targeted benefits.

Governments and healthcare institutions are also promoting research into personalized nutrition through grants and partnerships, which could accelerate innovation in this space. As awareness grows and technologies become more accessible, personalized oral clinical nutrition is likely to redefine product development strategies within industry.

Growing Integration of Oral Clinical Nutrition in Home Healthcare

The trend of incorporating oral clinical nutrition products into home healthcare settings is gaining momentum. Factors such as the aging population, rising healthcare costs, and patient preferences for in-home care are driving the adoption of home-based medical nutrition. Home healthcare enables patients recovering from surgery, managing chronic conditions, or undergoing long-term treatment to maintain nutritional intake without the need for hospital visits.

This shift has been facilitated by improvements in product packaging, shelf stability, and ease of use. Many oral clinical nutrition supplements are now available in ready-to-drink or powder formats, making them convenient for home administration by caregivers or patients themselves. Additionally, health and digital health platforms are enabling regular nutritional consultations and follow-ups, ensuring patients receive continuous care.

The COVID-19 pandemic further accelerated this trend, highlighting the need for decentralized healthcare solutions. Governments and health systems have responded by promoting community-based care, home nutrition programs, and subsidies for in-home nutritional products. As healthcare continues to shift towards more patient-centric and cost-effective models, home-based oral clinical nutrition will become an integral part of chronic disease management and recovery plans.

Segmental Insights

Indication Insights

Based on Indication, the cancer care segment accounted for the largest share in 2024. This prominence can be attributed to several factors, including the rising prevalence of cancer driven by unhealthy lifestyles, environmental factors, poor dietary habits, genetic predispositions, and weakened immune systems. As cancer rates continue to climb globally, the demand for early diagnosis and treatment has led to the widespread adoption of advanced therapies such as chemotherapy and radiation. While these treatments are essential in managing cancer, they often come with severe side effects that negatively impact patients' nutritional intake, leading to weight loss, malnutrition, and overall declines in physical health.

To address these nutritional challenges, the need for specialized oral clinical nutrition products has grown significantly within the cancer care segment. These products are designed to help patients maintain adequate nutrient levels, support recovery, and improve treatment outcomes by counteracting the effects of reduced appetite and impaired digestion caused by cancer therapies. For example, in April 2020, Esperer Onco Nutrition introduced oral clinical nutrition supplements such as Es-Fortitude and Es-Invigour. These products are formulated specifically for cancer patients experiencing weight loss due to chemotherapy and other treatments, providing essential nutrients in an easily consumable form to help manage malnutrition during treatment.

Download Free Sample Report

Regional Insights

Based on the region, North America held the largest market share in the global oral clinical nutrition market, owing to a combination of advanced healthcare infrastructure, high awareness of clinical nutrition, and strong presence of leading market players. The region benefits from well-established hospital networks, home healthcare services, and long-term care facilities that routinely incorporate oral clinical nutrition into patient care protocols. Additionally, North America has seen increasing demand for nutrition management among aging populations, individuals with chronic diseases, and patients recovering from surgeries or undergoing cancer treatments. Healthcare providers in North America are more inclined to adopt evidence-based nutritional therapy as a standard component of medical treatment, largely due to the growing recognition of the role nutrition plays in recovery and disease prevention. Furthermore, high consumer awareness, better affordability, and favorable reimbursement policies across many U.S. states and Canadian provinces contribute to widespread adoption of oral nutritional supplements in both hospital and outpatient settings.

Recent Developments

• In October 2023, Nutricia, part of Danone, launched its first medical nutrition drink, Fortini + Mix Multi Fibre, formulated to manage disease-related malnutrition and faltering growth in pediatric patients. The drink is ready to drink and provides 1/3 of the recommended daily intake of fruits and vegetables. Co-created with parents and younger patients, Fortini + Mix Multi Fibre is an innovative product within the Fortini pediatric feed range. The launch builds on Nutricia's expertise in medical nutrition solutions, supporting children with various medical conditions to grow and develop optimally.

Key Market Players

• Abbott Laboratories, Inc.
• Pfizer, Inc.
• Bayer AG
• Nestle SA
• GlaxoSmithKline plc
• Baxter International Inc.
• Otsuka Holdings, Co. Ltd.
• Baxter International Inc.
• Victus, Inc.
• Danone SA(Nutricia)

Report Scope:

In this report, the Global Oral Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Oral Clinical Nutrition Market, By Indication:

o   Alzheimer’s

o   Nutritional Deficiencies

o   Cancer Care

o   Chronic Kidney Disease

o   Dysphagia

o   Others

• Oral Clinical Nutrition Market, By Distribution Channel:

o   Direct Sales

o   Indirect Sales

• Oral Clinical Nutrition Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Oral Clinical Nutrition Market.

Available Customizations:

Global Oral Clinical Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Oral Clinical Nutrition Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]